Cite

HARVARD Citation

    Tebas, P. et al. (2021). Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial. EClinicalMedicine. p. . [Online]. 
  
Back to record